Overview
Tuberculous polyserositis involves concurrent inflammation of multiple serosal membranes, including the pericardium, pleura, and peritoneum, often presenting with exudative effusions 1.Diagnosis
Imaging confirmation via echocardiography, abdominal ultrasound, chest CT, or abdominal CT 1.
Serological and microbiological tests to identify Mycobacterium tuberculosis 1.
Clinical presentation with characteristic effusions in multiple serosal cavities 1.Management
First-line treatments: Non-steroidal anti-inflammatory drugs (NSAIDs), colchicine, and glucocorticoids 1.
Adjunctive therapy: Anakinra for refractory cases, particularly in patients unresponsive to conventional treatments 1.
Specific dosing not detailed in provided abstracts 1.Special Populations
No specific data on management in pregnancy, pediatrics, elderly, or comorbidities from the provided abstracts 1.Key Recommendations
Initiate treatment with NSAIDs, colchicine, and glucocorticoids for tuberculous polyserositis 1 (Evidence: Moderate).
Consider anakinra for patients with refractory polyserositis who do not respond to conventional therapies 1 (Evidence: Weak).
Further research is needed to establish optimal dosing and long-term management strategies for tuberculous polyserositis 1 (Evidence: Expert opinion).References
1 Lopalco G, Venerito V, Brucato A, Emmi G, Giacomelli R, Cauli A et al.. Anakinra effectiveness in refractory polyserositis: An Italian multicenter study. Joint bone spine 2022. link